M-END DMX- dexbrompheniramine maleate, dextromethorphan, Schemes and Mind Maps of Marketing

Download M-END DMX- dexbrompheniramine maleate, dextromethorphan and more Schemes and Mind Maps Marketing in PDF only on Docsity! M-END DMX- dexbrompheniramine maleate, dextromethorphan hydrobromide, pseudoephedrine hydrochloride liquid R. A. McNeil Company Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies. ---------- M-END DMX Drug Facts Active ingredients (in each 5 mL teaspoonful) Dexbrompheniramine Maleate 0.667 mg Dextromethorphan HBr 10 mg Pseudeophedrine HCl 20 mg Purpose Antihistamine Antitussive Cough Suppressant Nasal Decongestant Uses temporarily relieves these symptoms due to the common cold, hay fever (allergic rhinitis) or other upper respiratory allergies: runny nose sneezing itching of the nose or throat itchy, watery eyes cough due to minor throat and bronchial irritation nasal congestion reduces swelling of nasal passages Warnings Do not exceed recommended dosage. Do not use this product if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product Ask a doctor before use if you have a breathing problem such as emphysema or chronic bronchitis glaucoma trouble urinating due to an enlarged prostate gland a cough that lasts or is chronic such as occurs with smoking, asthma or emphysema a cough that occurs with too much phlegm (mucus) heart disease high blood pressure thyroid disease diabetes Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers. When using this product excitability may occur, especially in children may cause marked drowsiness avoid alcoholic drinks alcohol, sedatives, and tranquilizes may increase the drowsiness effect be careful when driving a motor vehicle or operating machinery Stop use and ask a doctor if cough or nasal congestion persists for more than 1 week, tends to recur, or is accompanied by a fever, rash or persistent headache. A persistent cough may be a sign of a serious condition. nervousness, dizziness, or sleeplessness occur new symptoms occur If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. Directions Do not exceed 4 doses in a 24 hour period. Adults and children 12 years of age and over: 3 teaspoonfuls (15 mL) every 6 hours, not to exceed 12 teaspoonfuls in 24 hours Children 6 to under 1 1/2 teaspoonfuls M-END DMX dexbrompheniramine maleate, dextromethorphan hydrobromide, pseudoephedrine hydrochloride liquid Product Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:12830-816 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength DEXBROMPHENIRAMINE MALEATE (UNII: BPA9UT29BS) (DEXBROMPHENIRAMINE - UNII:75T64B71RP) DEXBROMPHENIRAMINE MALEATE 0.667 mg in 5 mL DEXTROMETHORPHAN HYDROBROMIDE (UNII: 9D2RTI9KYH) (DEXTROMETHORPHAN - UNII:7355X3ROTS) DEXTROMETHORPHAN HYDROBROMIDE 10 mg in 5 mL PSEUDOEPHEDRINE HYDROCHLORIDE (UNII: 6V9V2RYJ8N) (PSEUDOEPHEDRINE - UNII:7CUC9DDI9F) PSEUDOEPHEDRINE HYDROCHLORIDE 20 mg in 5 mL Inactive Ingredients Ingredient Name Strength CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP) GLYCERIN (UNII: PDC6A3C0OX) PROPYLENE GLYCOL (UNII: 6DC9Q167V3) WATER (UNII: 059QF0KO0R) SODIUM CITRATE (UNII: 1Q73Q2JULR) SACCHARIN SODIUM (UNII: SB8ZUX40TY) SORBITOL (UNII: 506T60A25R) SUCRALOSE (UNII: 96K6UQ3ZD4) Product Characteristics Color Score Shape Size Flavor TUTTI FRUTTI Imprint Code Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:12830-816- 16 473 mL in 1 BOTTLE; Type 0: Not a Combination Product 10/13/2011 2 NDC:12830-816- 30 30 mL in 1 BOTTLE; Type 0: Not a Combination Product 10/13/2011 Marketing Information R. A. McNeil Company Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph final part341 10/13/2011 Labeler - R. A. McNeil Company (008305220) Revised: 11/2021